Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China-Biotics hits public offering target

This article was originally published in The Tan Sheet

Executive Summary

Probiotics manufacturer China-Biotics reports net proceeds of $65.5 million in its underwritten public offering of shares Oct. 5 on NASDAQ. It sold all of the 4.6 million shares of common stock it made available at $15 per share, the target price it set. The Shanghai-based firm said it intends to use the proceeds for general corporate purposes, including expanding its Shining retail operations and product lines and acquiring additional retail outlets. China-Biotics' products are available in pharmacies and supermarkets in Shanghai, Jiangsu and Zhejiang
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS103408

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel